Randomized Phase II Trial of Post-operative Adjuvant Chemotherapy +/- FANG Autologous Tumor Cell Vaccine in Colorectal Carcinoma With Liver Metastases.

Trial Profile

Randomized Phase II Trial of Post-operative Adjuvant Chemotherapy +/- FANG Autologous Tumor Cell Vaccine in Colorectal Carcinoma With Liver Metastases.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 02 Jul 2018

At a glance

  • Drugs Bi-shRNAfurin-GM-CSF-loaded tumour cell vaccine (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
  • Indications Colorectal cancer; Liver metastases
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms FANG-CLM
  • Sponsors Gradalis
  • Most Recent Events

    • 21 May 2018 Status changed from completed to discontinued.
    • 23 Feb 2017 Status changed from active, no longer recruiting to completed.
    • 06 Jun 2016 Planned End Date changed from 1 Mar 2016 to 1 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top